Cite
HARVARD Citation
Muehlan, C. et al. (2018). Accelerated Development of the Dual Orexin Receptor Antagonist ACT‐541468: Integration of a Microtracer in a First‐in‐Human Study. Clinical pharmacology & therapeutics. 104 (5), pp. 1022-1029. [Online].